Molecularly imprinted polymers for selective solid-phase extraction of verapamil from biological fluids and human urine

Current Pharmaceutical Analysis

Volumn 5, Issue 3, 2009, Pages 269-276

  Javanbakht, Mehran ^a   Shaabani, Narges ^b   Abdouss, Majid ^a   Ganjali, Mohammad R ^c   Mohammadi, Ali ^c   Norouzi, Parviz ^c  

^a AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Biological fluids; Human urine; Molecularly imprinted polymer; Solid phase extraction; Verapamil

Indexed keywords

VERAPAMIL;

ACCURACY; ARTICLE; BODY FLUID; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MOLECULAR IMPRINTING; MOLECULAR RECOGNITION; POLYMERIZATION; PRECIPITATION; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; ULTRAVIOLET SPECTROSCOPY; URINE;

EID: 75149124013     PISSN: 15734129     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341209788922011     Document Type: Article

References (33)

1. Komiyama, M.; Takeuchi, T.; Mukawa, T.; Asanuma, H.; Molecular imprinting: from fundamentals to applications, John Wiley & Sons, 2003.
2. Ye, L.; Haupt, K. Molecularly imprinted polymers as antibody and receptor mimics for assays, sensors and drug discovery. Anal. Bioanal, Chem., 2004, 378(8), 1887-1897.
3. Turiel, E.; Martin-Esteban, A. Molecularly imprinted polymers: Towards highly selective stationary phases in liquid chromatography and capillary electrophoresis. Anal. Bioanal. Chem., 2004, 378, 1876-1886.
4. Alexander, C.; Davidson, L.; Hayes, W. Imprinted polymers: Artificial molecular recognition materials with applications in synthesis and catalysis. Tetrahedron, 2003, 59, 2025-2057.
5. Martin-Esteban, A.; Fresenius, J. New molecular recognition materials for selective solid-phase extraction of organic compounds. Anal. Chem., 2001, 370, 795-802.
6. Caro, E.; Marce, R.M.; Borrull, F.; Cormack, P.A.G.; Sherrington, D.C. Application of molecularly imprinted polymers to solid-phase extraction of compounds from environmental and biological samples. Trends. Anal. Chem., 2006, 25, 143-145.
7. Pichon, V.; Haupt, K. Affinity Separations on molecularly imprinted polymers with special emphasis on solid-phase extraction J. Liq. Chromatogr. Relat. Technol., 2006, 29, 989-1023.
8. Tamayo, F.G.; Turiel, E.; Martin-Esteban, A. Molecularly imprinted polymers for solid-phase extraction and solid-phase microextraction: Recent developments and future trends. J. Chromatogr. A, 2007, 1152, 32-40.
9. Javanbakht, M.; Eynollahi Fard, S.; Mohammadi, A.; Abdouss, M.; Ganjali, M.R.; Norouzi, P.; Safaraliee, L. Molecularly imprinted polymer based potentiometric sensor for the determination of hydroxyzine in tablets and biological fluids. Anal. Chim. Acta, 2008, 612, 56-74.
10. Javanbakht, M.; Eynollahi Fard, S.; Abdouss, M.; Mohammadi, A.; Ganjali, M.R.; Norouzi, P.; Safaraliee, L. A biomimetic potentiometric sensor using molecularly imprinted polymer for the cetirizine assay in tablets and biological fluids. Electroanalysis, 2008, 20, 2023-2030.
11. Mullett, W.M.; Walles, M.; Levsen, K.; Borlak, J.; Pawliszyn, J. Multidimensional on-line sample preparation of verapamil and its metabolites by a molecularly imprinted polymer coupled to liquid chromatography-mass spectrometry. J. Chromatogr. B, 2004, 801, 297-306.
12. Patel, N.P.; Pugh, M.E.; Goldberg, S.; Eiger, G. Hyperinsulinemic euglycemia therapy for verapamil poisoning: Case Report. Am. J. Crit. Care., 2007, 16, 498-503.
13. Eisenberg, M.J.; Brox, A.; Bestawros, A.N. Major side effects and safety of calcium channel blockers. Am. J. Med., 2004, 116, 35-43.
14. British Pharmacopoeia, H.M. Stationery Office, London, 1998, Vol. I, pp. 1353-1354.
15. The United States Pharmacopoeia, National Formulary 18, The United States Pharmacopoeial Convention, XXIII ed, USA, Rockville, MD, 1995, pp. 1623-1626.
16. Ozkan, Y.; Yilmaz, N.; Ozkan, S.A.; Biryol, I. High performance liquid chromatographic assay and drug dissolution studies of fluoxetine hydrochloride in capsule formulations. J. Liq. Chromatogr. Relat. Technol., 2000, 23, 1699-1710.
17. ElGhany, M.F.A.; Moustafa, A.A.; ElZeany, B.E.; Stewart, J.T. High performance thin-layer chromatographic analysis of verapamil hydrochloride in drug substance and dosage forms. J. Planar Chromatogr. Mod. TLC, 1996, 9, 388-390.
18. Gumieniczek, A.; Hopkala, A. Development and validation of a liquid choromatographic method for the determination of trandolapril. J. Liq. Chromatogr. Relat. Technol., 2001, 24, 393-400.
19. Walash, M.; Belal, F.; El-Enany, N.; Abdelsalam, A. Spectrofluorometric determination of verapamil hydrochloride in pharmaceutical preparations and human plasma using organized media: application to stability studies. J. AOAC Int., 2006, 89, 1565-1572.
20. Xu, D.; Liu, S.; Liu, Z.; Hu, X. Determination of verapamil hydrochloride with 12-tungstophosphoric acid by resonance Rayleigh scattering method coupled to flow injection system. Anal. Chim. Acta, 2007, 588, 10-15.
21. Kasim, E.A.; Ghandour, M.A.; El-Haty, M.T., Ahmed, M.M. Determination of verapamil by adsorptive stripping voltammetry in urine and pharmaceutical formulations. J. Pharm. Biomed. Anal., 2002, 30, 921-929.
22. Khalil, S.; Kelzieh, A. Determination of verapamil in pharmaceutical formulations using atomic emission spectrometry. J. Pharm. Biomed. Anal., 2002, 27, 123-131.
23. Asafu-Adjaye, E. B.; Shiu, G. K. Solid-phase extraction-highperformance liquid chromatography determination of verapamil and norverapamil enantiomers in urine. J. Chromatogr. B., 1998, 707, 161-167.
24. Cheng, Y.F.; Neue, U.D. Bean, L. Straightforward solid-phase extraction method for the determination of verapamil and its metabolite in plasma in a 96-well extraction plate. J. Chromatogr. A, 1998, 828, 273-281.
25. Anthony C.M. Clarke,s Analysis of drugs and poisons in pharmaceuticals, Third ed., Pharmaceutical Press, 2004, Vol. 2, p. 1659.
26. Rachkov, A.; Minour, N. Molecular imprinting for the recognition of N-terminal histidine peptides in aqueous solution. J. Chromatogr. A, 2000, 889, 111-118.
27. Walles, M.; Mullett, W.M.; Levsen, K.; Borlak, J.; Wünsch, G.; Pawliszyn, J. Verapamil drug metabolism studies by automated intube solid phase microextraction. J. Pharm. Biomed. Anal. 2002, 30, 307-319.
28. Zi-Hui, M.; Qi, L. Determination of degradation products of nerve agents in human serum by solid phase extraction using molecularly imprinted polymer. Anal. Chim. Acta, 2001, 435, 121-127.
29. Cacho, C.; Turiel, E.; Matrin-Esteban, A.; Perez-Conde, C.; Camara, C. Characterisation and quality assessment of binding sites on a propazine-imprinted polymer prepared by precipitation polymerization. J. Chromatogr. B, 2004, 802, 347-353.
30. Martin, P.; Jones, G.R.; Stringer, F.; Wilson, I.D. Comparison of normal and reversed-phase solid phase extraction methods for extraction of β-blockers from plasma using molecularly imprinted polymers. Analyst, 2003, 128, 345-350.
31. Shea, K.J.; Spivak, D.A.; Sellergre, B. Influence of polymer morphology on the ability of imprinted network polymers to resolve enantiomers. J. Am. Chem. Soc., 1993, 115, 3368-3369.
32. Garcia, M.A.; Aramayona, J.J.; Bregante, M.A.; Fraile. L.J.; Solans, C. Simultaneous determination of verapamil and norverapamil in biological samples by high-performance liquid chromatography using ultraviolet detection. J. Chromatogr. B, 1997, 693(2), 377-382.
33. Miller, J. N.; Miller, J. C. Statistics and Chemometrics for Analytical Chemistry, Prentice Hall, England, 2000, Fourth Edition, 40.